MaaT Pharma (MAAT) Financial Statements

4 Followers

MaaT Pharma Financial Overview

MaaT Pharma's market cap is currently €102.78M. The company's EPS TTM is €-0.951; its P/E ratio is -1.26; MaaT Pharma is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 4.52M	€ 3.22M	€ 2.23M	€ 1.43M	€ 972.00K
Gross Profit	€ 1.39M	€ 1.97M	€ 784.00K	€ 1.09M	€ 806.00K
Operating Income	€ -34.15M	€ -28.43M	€ -19.94M	€ -13.56M	€ -8.89M
EBITDA	€ -32.41M	€ -26.34M	€ -22.07M	€ -13.10M	€ -8.57M
Net Income	€ -31.06M	€ -28.90M	€ -19.72M	€ -13.71M	€ -9.02M
Balance Sheet
Cash & Short-Term Investments	€ 24.87M	€ 20.22M	€ 24.31M	€ 35.31M	€ 43.30M
Total Assets	€ 44.55M	€ 38.50M	€ 42.93M	€ 44.73M	€ 49.42M
Total Debt	€ 17.44M	€ 15.96M	€ 14.07M	€ 11.36M	€ 5.81M
Net Debt	€ -7.43M	€ -4.20M	€ -10.21M	€ -23.89M	€ -37.50M
Total Liabilities	€ 42.75M	€ 28.16M	€ 22.46M	€ 17.91M	€ 9.56M
Stockholders' Equity	€ 1.80M	€ 10.34M	€ 20.47M	€ 26.81M	€ 39.86M
Cash Flow
Free Cash Flow	€ -16.52M	€ -22.79M	€ -19.76M	€ -13.27M	€ -8.17M
Operating Cash Flow	€ -15.91M	€ -22.04M	€ -18.67M	€ -12.61M	€ -7.93M
Investing Cash Flow	€ -497.00K	€ -416.00K	€ -440.00K	€ -815.00K	€ -238.00K
Financing Cash Flow	€ 21.12M	€ 18.33M	€ 8.14M	€ 5.36M	€ 31.56M

Currency in EUR

MaaT Pharma Earnings and Revenue History

Income Statement >

MaaT Pharma Debt to Assets

Balance Sheet >

MaaT Pharma Cash Flow

Cash Flow >

MaaT Pharma Forecast EPS vs Actual EPS

Earnings >